St Jude beefs up AF (atrial fibrillation) division with new acquisition
This article was originally published in Clinica
Executive Summary
Consistent with its vision to create a meaningful, "new and long term growth driver surrounding atrial fibrillation (AF)", St Jude Medical has acquired yet another player in the AF field. The company signed a definitive agreement to acquire Endocardial Solutions for $11.75 per share in cash, equivalent to a total purchase price of approximately $273m. The offer represents a premium of 17.5% to Endocardial's closing price of $10.00 on the day of the announcement (September 23). The company's share price shot up to $11.58 the following day.